Venn launches innovation division for co-development

by PharmaTimes | 1st Jan 2000 | News

Tags

Related posts

Kupando doses first patient in phase 1 trial

Kupando doses first patient in phase 1 trial

Aug 13, 2026

First-in-class house dust mite allergy treatment now available in Scotland

First-in-class house dust mite allergy treatment now available in Scotland

Aug 13, 2026

NHS backs new treatment option for cystinosis

NHS backs new treatment option for cystinosis

Aug 12, 2026

Fridge‑free vaccine shows global potential

Fridge‑free vaccine shows global potential

Aug 12, 2026

PharmaTimes Media Ltd.
44 Maiden Lane
Covent Garden
London
WC2E 7LN

E: editorial@pharmatimes.com
E: subscriptions@pharmatimes.com
T: +44 (0)20 7240 6999